{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:10:57Z","timestamp":1786983057814,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD065987"],"award-info":[{"award-number":["HD065987"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s43032-023-01402-w","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T16:41:14Z","timestamp":1700152874000},"page":"997-1005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Anti-TNF Biologic Exposure During Pregnancy on Villitis of Unknown Etiology Diagnoses in Patients with Autoimmune Disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Hannah M.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramila","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Branda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda V.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Norgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan N.","family":"Theiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-7335","authenticated-orcid":false,"given":"Elizabeth Ann L.","family":"Enninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"issue":"5","key":"1402_CR1","first-page":"e8094","volume":"12","author":"F Angum","year":"2020","unstructured":"Angum F, et al. The prevalence of autoimmune disorders in women: a narrative review. Cureus. 2020;12(5):e8094.","journal-title":"Cureus"},{"issue":"2","key":"1402_CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.gtc.2016.02.006","volume":"45","author":"RA McConnell","year":"2016","unstructured":"McConnell RA, Mahadevan U. Pregnancy and the patient with inflammatory bowel disease: fertility, treatment, delivery, and complications. Gastroenterol Clin North Am. 2016;45(2):285\u2013301.","journal-title":"Gastroenterol Clin North Am"},{"issue":"9","key":"1402_CR3","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1007\/s10620-015-3677-x","volume":"60","author":"A O'Toole","year":"2015","unstructured":"O\u2019Toole A, Nwanne O, Tomlinson T. Inflammatory bowel disease increases risk of adverse pregnancy outcomes: a meta-analysis. Dig Dis Sci. 2015;60(9):2750\u201361.","journal-title":"Dig Dis Sci"},{"key":"1402_CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/03009742.1998.11720781","volume":"107","author":"JF Skomsvoll","year":"1998","unstructured":"Skomsvoll JF, et al. Obstetrical and neonatal outcome in pregnant patients with rheumatic disease. Scand J Rheumatol Suppl. 1998;107:109\u201312.","journal-title":"Scand J Rheumatol Suppl"},{"key":"1402_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijms22062922","volume":"22","author":"K Romanowska-Pr\u00f3chnicka","year":"2021","unstructured":"Romanowska-Pr\u00f3chnicka K, et al. The role of TNF-\u03b1 and anti-TNF-\u03b1 agents during preconception, pregnancy, and breastfeeding. Int J Mol Sci. 2021;22:6.","journal-title":"Int J Mol Sci"},{"key":"1402_CR6","first-page":"5","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang DI, et al. The role of tumor necrosis factor alpha (TNF-alpha) in autoimmune disease and current TNF-alpha inhibitors in therapeutics. Int J Mol Sci. 2021;22:5.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 3","key":"1402_CR7","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1\u2013106.","journal-title":"Gut"},{"issue":"5","key":"1402_CR8","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","volume":"156","author":"U Mahadevan","year":"2019","unstructured":"Mahadevan U, et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology. 2019;156(5):1508\u201324.","journal-title":"Gastroenterology"},{"issue":"4","key":"1402_CR9","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","volume":"62","author":"MD Russell","year":"2023","unstructured":"Russell MD, et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023;62(4):e48\u201388.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1402_CR10","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/1471-0528.17093","volume":"129","author":"LJ O'Byrne","year":"2022","unstructured":"O\u2019Byrne LJ, et al. Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: a systematic review and meta-analysis. BJOG. 2022;129(8):1236\u201346.","journal-title":"BJOG"},{"issue":"10","key":"1402_CR11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.placenta.2013.07.002","volume":"34","author":"JA Tamblyn","year":"2013","unstructured":"Tamblyn JA, et al. The immunological basis of villitis of unknown etiology - review. Placenta. 2013;34(10):846\u201355.","journal-title":"Placenta"},{"issue":"3","key":"1402_CR12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0897.1986.tb00068.x","volume":"12","author":"CA Labarrere","year":"1986","unstructured":"Labarrere CA, et al. Placental lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol. 1986;12(3):78\u201386.","journal-title":"Am J Reprod Immunol Microbiol"},{"issue":"8","key":"1402_CR13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.puhe.2014.06.022","volume":"128","author":"J Gardosi","year":"2014","unstructured":"Gardosi J, et al. Preventing stillbirths through improved antenatal recognition of pregnancies at risk due to fetal growth restriction. Public Health. 2014;128(8):698\u2013702.","journal-title":"Public Health"},{"issue":"6","key":"1402_CR14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1189\/jlb.68.6.903","volume":"68","author":"MI Garcia-Lloret","year":"2000","unstructured":"Garcia-Lloret MI, WinklerLowen B, Guilbert LJ. Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-alpha. A model for hematogenous initiation of placental inflammations. J Leukoc Biol. 2000;68(6):903\u20138.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"1402_CR15","doi-asserted-by":"crossref","first-page":"e0157584","DOI":"10.1371\/journal.pone.0157584","volume":"11","author":"IC Weel","year":"2016","unstructured":"Weel IC, et al. Association between placental lesions, cytokines and angiogenic factors in pregnant women with preeclampsia. PLoS ONE. 2016;11(6):e0157584.","journal-title":"PLoS ONE"},{"issue":"1","key":"1402_CR16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0008-6363(02)00844-1","volume":"58","author":"N Anim-Nyame","year":"2003","unstructured":"Anim-Nyame N, et al. Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia. Cardiovasc Res. 2003;58(1):162\u20139.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1402_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-0378(01)00069-9","volume":"51","author":"SJ Babbage","year":"2001","unstructured":"Babbage SJ, et al. Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss. J Reprod Immunol. 2001;51(1):21\u20137.","journal-title":"J Reprod Immunol"},{"key":"1402_CR18","doi-asserted-by":"crossref","first-page":"718563","DOI":"10.3389\/fimmu.2021.718563","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, et al. Type 1 Cytotoxic T Cells Increase in Placenta after Intrauterine Inflammation. Front Immunol. 2021;12:718563.","journal-title":"Front Immunol"},{"issue":"3","key":"1402_CR19","doi-asserted-by":"crossref","first-page":"e0001322","DOI":"10.1128\/iai.00013-22","volume":"90","author":"AY Tsai","year":"2022","unstructured":"Tsai AY, et al. Tumor necrosis factor alpha contributes to inflammatory pathology in the placenta during Brucella abortus infection. Infect Immun. 2022;90(3):e0001322.","journal-title":"Infect Immun"},{"issue":"7","key":"1402_CR20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","volume":"140","author":"TY Khong","year":"2016","unstructured":"Khong TY, et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med. 2016;140(7):698\u2013713.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"1402_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5114\/pjp.2017.67616","volume":"68","author":"J Stanek","year":"2017","unstructured":"Stanek J. Placental infectious villitis versus villitis of unknown etiology. Pol J Pathol. 2017;68(1):55\u201365.","journal-title":"Pol J Pathol"},{"issue":"5","key":"1402_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3109\/01443611003802339","volume":"30","author":"L Feeley","year":"2010","unstructured":"Feeley L, Mooney EE. Villitis of unknown aetiology: correlation of recurrence with clinical outcome. J Obstet Gynaecol. 2010;30(5):476\u20139.","journal-title":"J Obstet Gynaecol"},{"issue":"10","key":"1402_CR23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.humpath.2007.05.025","volume":"38","author":"RW Redline","year":"2007","unstructured":"Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol. 2007;38(10):1439\u201346.","journal-title":"Hum Pathol"},{"key":"1402_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.placenta.2021.07.298","volume":"112","author":"AA Freedman","year":"2021","unstructured":"Freedman AA, Miller GE, Ernst LM. Chronic villitis: refining the risk ratio of recurrence using a large placental pathology sample. Placenta. 2021;112:135\u201340.","journal-title":"Placenta"},{"issue":"6","key":"1402_CR25","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.4049\/jimmunol.0803834","volume":"182","author":"MJ Kim","year":"2009","unstructured":"Kim MJ, et al. Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J Immunol. 2009;182(6):3919\u201327.","journal-title":"J Immunol"},{"key":"1402_CR26","doi-asserted-by":"crossref","first-page":"705219","DOI":"10.3389\/fimmu.2021.705219","volume":"12","author":"M Shahi","year":"2021","unstructured":"Shahi M, et al. Expression of immune checkpoint receptors in placentae with infectious and non-infectious chronic villitis. Front Immunol. 2021;12:705219.","journal-title":"Front Immunol"},{"issue":"5","key":"1402_CR27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s43032-019-00101-9","volume":"27","author":"EAL Enninga","year":"2020","unstructured":"Enninga EAL, et al. Upregulation of HLA-class I and II in placentas diagnosed with villitis of unknown etiology. Reprod Sci. 2020;27(5):1129\u201338.","journal-title":"Reprod Sci"},{"key":"1402_CR28","doi-asserted-by":"crossref","first-page":"103438","DOI":"10.1016\/j.jri.2021.103438","volume":"148","author":"M Ars\u00e8ne","year":"2021","unstructured":"Ars\u00e8ne M, et al. Chronic Villitis of unknown etiology (VUE): Obstetrical features, outcome and treatment. J Reprod Immunol. 2021;148:103438.","journal-title":"J Reprod Immunol"},{"key":"1402_CR29","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"1402_CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, et al. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"1","key":"1402_CR31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9378(98)70277-7","volume":"179","author":"MS Magid","year":"1998","unstructured":"Magid MS, et al. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol. 1998;179(1):226\u201334.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1402_CR32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ajpath.2015.12.010","volume":"186","author":"H Derricott","year":"2016","unstructured":"Derricott H, et al. Characterizing villitis of unknown etiology and inflammation in stillbirth. Am J Pathol. 2016;186(4):952\u201361.","journal-title":"Am J Pathol"},{"issue":"3","key":"1402_CR33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/15513819109064774","volume":"11","author":"CM Salafia","year":"1991","unstructured":"Salafia CM, et al. Distribution of ICAM-1 within decidua and placenta and its gestational age-associated changes. Pediatr Pathol. 1991;11(3):381\u20138.","journal-title":"Pediatr Pathol"},{"issue":"1","key":"1402_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cpt.1827","volume":"108","author":"GAM Eliesen","year":"2020","unstructured":"Eliesen GAM, et al. Assessment of placental disposition of infliximab and etanercept in women with autoimmune diseases and in the ex vivo perfused placenta. Clin Pharmacol Ther. 2020;108(1):99\u2013106.","journal-title":"Clin Pharmacol Ther"},{"key":"1402_CR35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.5114\/ada.2020.102089","volume":"37","author":"W Owczarek","year":"2020","unstructured":"Owczarek W, et al. The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines. Advances in Dermatology and Allergology\/Post\u0229py Dermatologii i Alergologii. 2020;37:821\u201330.","journal-title":"Advances in Dermatology and Allergology\/Post\u0229py Dermatologii i Alergologii"},{"issue":"1","key":"1402_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0897.2008.00585.x","volume":"60","author":"EE Winger","year":"2008","unstructured":"Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008;60(1):8\u201316.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"1402_CR37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ajg.2008.71","volume":"104","author":"SV Kane","year":"2009","unstructured":"Kane SV, Acquah LA. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol. 2009;104(1):228\u201333.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1402_CR38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","volume":"77","author":"X Mariette","year":"2018","unstructured":"Mariette X, et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228\u201333.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1402_CR39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/flgastro-2014-100430","volume":"6","author":"P Hendy","year":"2015","unstructured":"Hendy P, Chadwick G, Hart A. IBD: reproductive health, pregnancy and lactation. Frontline Gastroenterol. 2015;6(1):38\u201343.","journal-title":"Frontline Gastroenterol"},{"issue":"3","key":"1402_CR40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.gtc.2014.05.005","volume":"43","author":"S Horst","year":"2014","unstructured":"Horst S, Kane S. The use of biologic agents in pregnancy and breastfeeding. Gastroenterol Clin North Am. 2014;43(3):495\u2013508.","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"1402_CR41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.20344\/amp.11482","volume":"32","author":"J Roseira","year":"2019","unstructured":"Roseira J, Ramos J. A narrative review on anti-tumor necrosis factor \u03b1 therapies in inflammatory bowel disease during pregnancy: immunoglobulin placental translocation and its impact. Acta Med Port. 2019;32(4):305\u201312.","journal-title":"Acta Med Port"},{"key":"1402_CR42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.placenta.2022.02.006","volume":"120","author":"L de Koning","year":"2022","unstructured":"de Koning L, et al. Recurrence risk of villitis of unknown etiology: analysis of a large retrospective cohort study, systematic review and meta-analysis. Placenta. 2022;120:32\u20139.","journal-title":"Placenta"},{"key":"1402_CR43","doi-asserted-by":"crossref","first-page":"825075","DOI":"10.3389\/fimmu.2022.825075","volume":"13","author":"EF Cornish","year":"2022","unstructured":"Cornish EF, Mcdonnell T, Williams DJ. chronic inflammatory placental disorders associated with recurrent adverse pregnancy outcome. Front Immunol. 2022;13:825075.","journal-title":"Front Immunol"},{"key":"1402_CR44","doi-asserted-by":"crossref","first-page":"945543","DOI":"10.3389\/fendo.2022.945543","volume":"13","author":"L Moar","year":"2022","unstructured":"Moar L, et al. Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis. Front Endocrinol (Lausanne). 2022;13:945543.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1402_CR45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0368-2315(06)76411-0","volume":"35","author":"G Boog","year":"2006","unstructured":"Boog G, et al. Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology. J Gynecol Obstet Biol Reprod (Paris). 2006;35(4):396\u2013404.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"9","key":"1402_CR46","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/jog.13404","volume":"43","author":"N Ozawa","year":"2017","unstructured":"Ozawa N, et al. Chronic histiocytic intervillositis in three consecutive pregnancies in a single patient: differing clinical results and pathology according to treatment used. J Obstet Gynaecol Res. 2017;43(9):1504\u20138.","journal-title":"J Obstet Gynaecol Res"},{"key":"1402_CR47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejogrb.2019.02.036","volume":"236","author":"A Mekinian","year":"2019","unstructured":"Mekinian A, et al. Antagonists of TNF\u03b1 for recurrent miscarriages: 2 illustrative cases. Eur J Obstet Gynecol Reprod Biol. 2019;236:263\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1402_CR48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aji.12493","volume":"76","author":"A Mekinian","year":"2016","unstructured":"Mekinian A, et al. Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation? Am J Reprod Immunol. 2016;76(1):8\u201328.","journal-title":"Am J Reprod Immunol"},{"issue":"11","key":"1402_CR49","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.4049\/jimmunol.1901297","volume":"204","author":"EAL Enninga","year":"2020","unstructured":"Enninga EAL, et al. Maternal T cells in the human placental villi support an allograft response during noninfectious villitis. J Immunol. 2020;204(11):2931\u20139.","journal-title":"J Immunol"},{"key":"1402_CR50","unstructured":"Langston C, Kaplan C, Macpherson T, Manci E, Peevy K, Clark B, Murtagh C, Cox S, Glenn G. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med. 1997;121(5):449\u201376."},{"issue":"5","key":"1402_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ajog.2022.12.017","volume":"228","author":"DJ Roberts","year":"2023","unstructured":"Roberts DJ, Baergen RN, Boyd TK, Carreon CK, Duncan VE, Ernst LM, Faye-Petersen OM, Folkins AK, Hecht JL, Heerema-McKenney A, Heller DS, Linn RL, Polizzano C, Ravishankar S, Redline RW, Salafia CM, Torous VF, Castro EC. Criteria for placental examination for obstetrical and neonatal providers. Am J Obstet Gynecol. 2023;228(5):497\u2013508.e4. https:\/\/doi.org\/10.1016\/j.ajog.2022.12.017.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1402_CR52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/plac.2002.0875","volume":"24","author":"A Altemani","year":"2003","unstructured":"Altemani A, Gonzatti A, Metze K. How many paraffin blocks are necessary to detect villitis? Placenta. 2003;24(1):116\u20137.","journal-title":"Placenta"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-023-01402-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-023-01402-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-023-01402-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T14:28:49Z","timestamp":1711117729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-023-01402-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1007\/s43032-023-01402-w","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"assertion":[{"value":"21 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Mayo Clinic Institutional Review Board, application #22\u20130016101, on June 16, 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Only data from patients who provided Minnesota Research Authorization was gathered for this analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have read, reviewed, and approved the work submitted in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"SVK is a consultant for Fresenius Kabi and Janssen, which both produce anti-TNF molecules. RNT is an advisor to Delfina and has a know-how agreement with HeraMed. The remaining authors report no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}